Analysis of 65 patients with DLBCL receiving R-DHAP as a salvage regimen.
Modified R-DHAP with administration of cisplatin over 4 consecutive days.
Overall response rate (CR, CRu, PR) of 66% after 1 to 2 cycles.
Modified R-DHAP regimen efficiently mobilizes CD34+ cells for PBSC collection.
PBSC harvest after the first cycle of R-DHAP yielded significantly more CD34+ cells.